Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 28;48(84):10416-8.
doi: 10.1039/c2cc35044k. Epub 2012 Sep 17.

Reengineered epipodophyllotoxin

Affiliations

Reengineered epipodophyllotoxin

Igor V Magedov et al. Chem Commun (Camb). .

Abstract

A variant structural skeleton of epipodophyllotoxin was synthesized and found to rival the natural cyclolignan in antiproliferative and microtubule destabilizing properties. This discovery leads to a new structural class of tubulin targeting agents.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of podophyllotoxin (1), epipodophyllotoxin (2), etoposide (3) and teniposide (4).
Figure 2
Figure 2
Is systematic interrogation of the chemical space occupied by rings AB and E possible?
Figure 3
Figure 3
Strategy leading to reengineered epipodophyllotoxin 11.
Figure 4
Figure 4
Molecular docking poses (black) of 21 (A) and 11 (B) overlaid with that of 1 (red).
Figure 5
Figure 5
Microtubule organization in HeLa cells during interphase (A–E) and mitosis (F–J). Hela cells were treated for 3 hours with the indicated compounds at their MTT-related GI50 concentrations (see Table). Following drug treatment, cells were probed for microtubules (green), centromeres (red) and DNA (blue). Bar, 10μ.
Scheme 1
Scheme 1
Synthesis of Diels-Alder products 18 (exo) and 19 (endo)
Scheme 2
Scheme 2
Elaboration of the Diels-Alder products 18 and 19 to reengineered epipodophyllotoxin 11 and its C-3 epimer 24.

References

    1. Imbert TF. Biochimie. 1998;80:207–222. - PubMed
    1. Bastos JK, Burnadt CL, Nanayakkara NPD, Bryant L, McChesney JD. J Nat Prod. 1996;59:406–408.
    1. Bohlin L, Rosen B. Drug Discov Today. 1996;1:343–351.
    1. You YJ. Curr Pharm Des. 2005;11:1695–1717. - PubMed
    1. Gordaliza M, Castro MA, Corral JMM, San Feliciano A. Curr Pharm Des. 2000;6:1811–1839. - PubMed

MeSH terms

Substances